EP302: The Gigantic Problem I Have With Talk About Telehealth, With Blake McKinney, MD, From CirrusMD
December 03, 2020
302
31:05

EP302: The Gigantic Problem I Have With Talk About Telehealth, With Blake McKinney, MD, From CirrusMD

Sometimes when I overhear a conversation/argument about telehealth, it occurs to me that there’s a lot of fighting words about some things and very, very little about other things which I’d regard as equally, or maybe even more, important. Some of the sparring tends to jump immediately to tactics and UX (user experience), absent of strategy and CX (customer experience). In my experience, you can’t talk about a user interface until you talk about the overall customer experience and journey and what your goal is.

So, here’s what I mean: Let’s take urgent care as an analog. Say a patient goes to urgent care with symptoms consistent of allergic asthma. The NP (nurse practitioner) gives the patient strict instructions to take an antihistamine and Flonase and Flovent. She tells the patient to be sure to make a follow-up with their PCP (primary care provider) to evaluate how it’s going.

If the patient doesn’t make a follow-up visit, do we suggest it’s because the live in-person visit should have been telehealth? Or if the patient is nonadherent and winds up in the hospital with a full-blown asthma attack, do we suggest that live in-person visits diminish adherence? Let me respectfully suggest that it’d be a solid no on that.

This is exactly why, whenever I listen to a diatribe about how telehealth did not work out for a patient, I find it interesting to ask a couple of questions. The question that I tend to ask when someone starts talking about some telehealth fail is “How did it fail?” How did it not work out? And the answer to this question tends to be similar to the above allergic asthma example: that the patient needed lab work or imaging or a follow-up visit, and that couldn’t be done via telehealth. There was no resolution to the patient concern, in other words.

Okay … so, first of all, most practices don’t have immediate on-premises lab work or imaging, so the patient would have had to have gone somewhere else to get it anyway. But even if they did, as far as I know, you can’t have a follow-up visit at the same time that you have the first visit. Not to be cheeky, but that’s why they call it a follow-up visit.

Then the next logical question is, if the patient doesn’t show up for a follow-up, if the patient were in person, what’s the greater likelihood that they would have gone for the lab test and/or come back for the follow-up? This is when you start to realize that the setting of care (ie, virtual or in person) may be a little bit less important than the agency of the provider involved. And it may be a little less important than the structure of the organization sitting around that patient encounter. Said another way, strategically, what are we doing here? What are we trying to accomplish? What’s our road map to get the patient from where they are now to wherever that goal is?

A patient visit is a tactic. It’s one point in time. And that’s true regardless of whether it’s a remote visit or an in-person one, synchronous or asynchronous. A patient visit or interaction is not a care pathway. It is rarely, if ever, a magic bullet one and done. But that doesn’t stop us from thinking about patient encounters, one encounter at a time, which may be exactly why we wound up with a fragmented health care system that doesn’t work very well. But I digress.

So, from what I can see, some of the flaws that some people attribute to telehealth might be more properly construed as flaws to the ecosystem in which the telehealth is being deployed. For example, how much agency or data or infrastructure does the provider behind the camera have to see where the patient is in their treatment journey and make sure that they get to that next milestone? Because in cases where the doctor behind the camera or the telephone or the text message has agency and the telehealth visit is part of a defined patient journey, telehealth results are strikingly comparable to not telehealth results, if not better. If we’re contemplating a patient journey or a treatment journey, writ large, the site of care at any moment in time is a secondary or tertiary factor—certainly not a primary one.

Here’s what I want to know about telehealth. How do you best use it, not as a point solution but as part of a larger whole? How do you optimize a telehealth encounter so it pulls its weight in helping patients get a resolution to their chief complaint or manage their chronic conditions? Christian Milaster has written about this in his Telehealth Tuesday newsletter, which is great, by the way. Christian wrote that the delivery of care, when viewed through the eyes of a systems engineer (which he is), becomes a quite simple four-step process. These are the four steps that Christian says. He says, the first step is assessment, which leads to a diagnosis, which is step two. Step three is the development of a treatment plan. And then step four is the implementation of that treatment plan.  

Amongst other sidebars, I talk about these four steps in this health care podcast with Blake McKinney, MD. Dr. McKinney is an ER doc as well as the cofounder and CMO over at CirrusMD. In our conversation, Dr. McKinney actually comes up with one more step to add to the four-step process. It’s kind of a pre-step, where the patient decides that he or she needs care to begin with.

You can learn more at cirrusmd.com.  

Blake McKinney, MD, cofounder of CirrusMD, had a vision: to enable every person to have a better experience accessing health care services. Blake observed the barriers his patients were up against in seeking care and, at the same time, saw that his friends and family were able to reach out to him directly for guidance, most often via text. CirrusMD was created so everyone seeking care could immediately connect and communicate with a real doctor in this way.

Partnering with Andy Altorfer in 2012, Blake and the CirrusMD team have built a platform to achieve this vision of an improved health care experience. Through the years, this path has been guided by Blake’s clinical insight and ongoing, practice-based understanding of the needs of both patients and doctors.

Dr. McKinney completed his internship and residency at the University of California Davis after graduating from the University of Texas Medical School in Houston. Prior to medical school, he served 4 years as a communications intelligence officer in the United States Marine Corps.


06:53 “Regardless of the availability of convenient options, there is one force more powerful than convenience, and that is familiarity.”
09:01 “Telemedicine that is continuity based is going to be better medicine fundamentally.”
13:21 “The fundamentals of medicine are the same, and the standard of care is the same, whether the care is in person or in clinic.”
15:16 What’s the underlying determinant of patient success?
16:08 “When it comes to the ‘What’s next,’ doctors love resources.”
16:52 How is telemedicine lacking in resources?
18:42 “Implementation to me is, first and foremost, about follow-up.”
23:10 “There’s a place for automations. My prime directive … is to build trust.”
25:13 “The best adaptive interview that you can create is human to human.”

You can learn more at cirrusmd.com.

healthcare,telehealth,telemedicine,healthtech,digitalhealth,cirrusmd,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuideAnn Kempski, Spencer Allen, Scott Tromanhauser, 
Steven Elkins, Matthew Bunte, and Lori Smith.

Recent Episodes

EP525: PMPM vs FFS—The Perverse Incentives Plan Sponsors Sometimes Miss, With Cristin Dickerson, MD
Relentless Health ValueAugust 19, 2026
525
16:3315.14 MB

EP525: PMPM vs FFS—The Perverse Incentives Plan Sponsors Sometimes Miss, With Cristin Dickerson, MD

Listen on Your Favorite App So, this one's gonna be a little bit different. Back last year, I sat down with Dr. Cristin Dickerson. She is the founding partner of Green Imaging , which is a physician-led radiology network doing direct contracting for imaging. And we talked about how imaging can run 6...

EP524: Beating Provider Network Pricing Games by Thinking About Buying Healthcare Like a Manufacturer Supply Chain, With John Quinn
Relentless Health ValueAugust 12, 2026
524
17:0215.59 MB

EP524: Beating Provider Network Pricing Games by Thinking About Buying Healthcare Like a Manufacturer Supply Chain, With John Quinn

Listen on Your Favorite App Hello, all you Relentless Tribe members. First off here, I would like to thank Casey Cormier for the really nice recurring donation. Thank you so much, Casey Cormier from  Stratis Group . Lately, traditional provider networks are increasingly being called into questi...

EP523: The Sleeping Giants of Healthcare—Why Self-insured Employers and Clinicians Keep Missing Each Other, With Suhas Gondi, MD, MBA
Relentless Health ValueAugust 05, 2026
523
35:1632.28 MB

EP523: The Sleeping Giants of Healthcare—Why Self-insured Employers and Clinicians Keep Missing Each Other, With Suhas Gondi, MD, MBA

Listen on Your Favorite App Hello, all you Relentless Tribe members. Before we dive in today, I just wanted to give a quick but massive thank you to Alex Sommers, MD, ABEM, DipABLM, from Astia Health for his generous gift, which we are going to use to help fund a camera for the podcast here to level...

EP522: How Exactly Does GoodRx Make Money? With Ge Bai, PhD, CPA
Relentless Health ValueJuly 29, 2026
522
13:4512.58 MB

EP522: How Exactly Does GoodRx Make Money? With Ge Bai, PhD, CPA

Listen on Your Favorite App Arielle Bose: Hi, Stacey. This is Arielle Bose from EHD Insurance . Big fan of the podcast. We were talking about GoodRx the other day, and it occurred to me that I’m not exactly clear about how they make money. So, Stacey, how does GoodRx make money? For a full transcrip...

EP521: How Revenue Cycle Management (RCM) Became an Over $200 Billion Healthcare Hot Potato, With Andrew Tsang
Relentless Health ValueJuly 22, 2026
521
36:1333.15 MB

EP521: How Revenue Cycle Management (RCM) Became an Over $200 Billion Healthcare Hot Potato, With Andrew Tsang

Listen on Your Favorite App Hey, welcome to Relentless Health Value. Okay … so, on today's show, we are talking about (Andrew Tsang and I) revenue cycle management, which—I say this with real affection—is maybe the least sexy phrase in all of healthcare. It sounds like a back-office spreadsheet prob...

EP520: Cash-Pay Generic Drugs Are a Functioning Market in Healthcare—Policymakers Beware and Be Careful
Relentless Health ValueJuly 15, 2026
520
32:1829.56 MB

EP520: Cash-Pay Generic Drugs Are a Functioning Market in Healthcare—Policymakers Beware and Be Careful

Listen on Your Favorite App In the pachinko machine that is the healthcare industry, with just so many intermediaries, with so much regulatory capture and conflicts of interest that may or may not be visible, so much margin that is shrouded in mystery in an ecosystem as messy as this with so many va...

EP519: The Current State of Primary Care—Inevitable or Fixable? With Lisa Rosenbaum, MD
Relentless Health ValueJuly 08, 2026
519
40:0036.61 MB

EP519: The Current State of Primary Care—Inevitable or Fixable? With Lisa Rosenbaum, MD

Listen on Your Favorite App Hello, all you Relentless Tribe members. Today, let's start here. Right now, we are watching a very visible exodus of brilliant, consummate primary care (and other, honestly) physicians leaving traditional practice for concierge medicine or otherwise. For a full transcrip...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.